file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 57415, GCS 264399, CR 412613 Collection span: 1954 - 2011 | |
Word(i) List (8769) Word count: 64224, All words count: 94915 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
301 | RESULTS | 41 | 252 | 1175 |
302 | AFRICAN | 37 | 301 | 1172 |
303 | RECENT | 49 | 181 | 1171 |
304 | FAMILIAL | 39 | 378 | 1168 |
305 | CARCINOMAS | 15 | 42 | 1167 |
306 | CHANGES | 52 | 185 | 1166 |
307 | AFLATOXIN | 20 | 97 | 1158 |
308 | ANALYSES | 6 | 42 | 1157 |
309 | ENDEMIC | 30 | 324 | 1156 |
310 | ONTOGENETIC | 1 | 4 | 1148 |
311 | CHROMATOGRAPHY | 43 | 143 | 1142 |
312 | MEASUREMENT | 13 | 19 | 1141 |
313 | CYTOPLASMIC | 12 | 294 | 1137 |
314 | STARCH | 21 | 96 | 1136 |
315 | DERIVED | 38 | 121 | 1133 |
316 | MOTHERS | 24 | 340 | 1130 |
317 | MICROSCOPY | 25 | 358 | 1129 |
318 | RATIO | 39 | 312 | 1126 |
319 | PEPTIDE | 27 | 147 | 1124 |
320 | FLUID | 37 | 161 | 1122 |
321 | LIGAND | 4 | 15 | 1113 |
322 | HEALTH | 46 | 127 | 1109 |
323 | SEQUENCES | 21 | 186 | 1105 |
324 | INITIATION | 7 | 22 | 1104 |
325 | MUTATIONS | 35 | 109 | 1098 |
326 | FIBRINOGEN | 4 | 17 | 1089 |
327 | DANE | 17 | 181 | 1088 |
328 | INHERITANCE | 22 | 400 | 1087 |
329 | CAUSE | 23 | 31 | 1083 |
330 | PROGRESSION | 10 | 31 | 1083 |
# | Word | Recs | TLCS | TGCS |
331 | LINE | 23 | 213 | 1078 |
332 | NOVEL | 57 | 134 | 1069 |
333 | INFLAMMATORY | 18 | 59 | 1067 |
334 | CARCINOGENS | 6 | 16 | 1060 |
335 | SUBTYPE | 27 | 227 | 1059 |
336 | GLYCOPROTEIN | 30 | 114 | 1054 |
337 | CONSEQUENCES | 13 | 85 | 1051 |
338 | VARIANT | 47 | 399 | 1050 |
339 | AGENTS | 51 | 264 | 1048 |
340 | APOLIPOPROTEIN | 34 | 112 | 1044 |
341 | SEVERE | 13 | 93 | 1035 |
342 | METHODS | 41 | 310 | 1033 |
343 | VERTICAL | 15 | 293 | 1033 |
344 | VITRO | 59 | 213 | 1028 |
345 | GLYCOSYLATION | 35 | 267 | 1027 |
346 | HBS | 82 | 228 | 1026 |
347 | MALARIA | 35 | 115 | 1019 |
348 | CHINESE | 35 | 268 | 1011 |
349 | LARGE | 30 | 151 | 1008 |
350 | NEOPLASIA | 10 | 95 | 1007 |
351 | HORMONE | 37 | 62 | 1006 |
352 | ISOLATED | 45 | 148 | 1004 |
353 | PREALBUMIN | 22 | 95 | 1004 |
354 | GEL | 50 | 248 | 1003 |
355 | LITERATURE | 27 | 44 | 1002 |
356 | EVOLUTIONARY | 8 | 39 | 1001 |
357 | INTEGRATION | 6 | 218 | 1001 |
358 | CONNECTIVE | 14 | 30 | 1000 |
359 | FREQUENCY | 53 | 393 | 995 |
360 | LIGHT | 20 | 426 | 995 |
# | Word | Recs | TLCS | TGCS |
361 | STRATEGIES | 15 | 51 | 990 |
362 | EVALUATION | 77 | 138 | 986 |
363 | COUNT | 1 | 3 | 984 |
364 | BASED | 41 | 176 | 979 |
365 | GENOTYPES | 14 | 120 | 977 |
366 | PRODUCT | 13 | 170 | 977 |
367 | CONSIDERATIONS | 22 | 208 | 974 |
368 | HAPTOGLOBINS | 33 | 427 | 974 |
369 | INFECTIVITY | 19 | 423 | 974 |
370 | SOUTHERN | 29 | 160 | 972 |
371 | REFERENCE | 30 | 132 | 971 |
372 | ILLNESS | 6 | 204 | 970 |
373 | LINKED | 43 | 276 | 965 |
374 | AGE | 36 | 114 | 962 |
375 | PROGNOSIS | 21 | 87 | 960 |
376 | MACROMOLECULES | 4 | 15 | 958 |
377 | SEROLOGICAL | 55 | 276 | 958 |
378 | TEST | 51 | 411 | 951 |
379 | PERSISTENCE | 27 | 353 | 948 |
380 | DYNAMICS | 18 | 104 | 944 |
381 | POTENTIAL | 46 | 190 | 944 |
382 | AMINO | 40 | 311 | 943 |
383 | GELS | 10 | 56 | 942 |
384 | CANCERS | 19 | 36 | 941 |
385 | MANAGEMENT | 37 | 92 | 938 |
386 | FERRITIN | 50 | 289 | 937 |
387 | NORTH | 25 | 145 | 936 |
388 | DIRECT | 16 | 287 | 932 |
389 | TUMOR | 41 | 130 | 928 |
390 | AMARUS | 54 | 540 | 922 |
# | Word | Recs | TLCS | TGCS |
391 | TECHNIQUE | 31 | 471 | 912 |
392 | SYNOVIAL | 38 | 135 | 908 |
393 | FAILURE | 39 | 188 | 905 |
394 | LIQUID | 25 | 81 | 905 |
395 | MUCOPOLYSACCHARIDES | 12 | 18 | 903 |
396 | GLOMERULONEPHRITIS | 13 | 130 | 899 |
397 | DESIGN | 11 | 9 | 897 |
398 | TECHNIQUES | 21 | 279 | 896 |
399 | DISTINCT | 8 | 206 | 889 |
400 | JAPANESE | 32 | 417 | 883 |
401 | CATTLE | 46 | 137 | 879 |
402 | INHERITED | 37 | 378 | 875 |
403 | INVITRO | 31 | 294 | 873 |
404 | VITAMIN | 23 | 40 | 873 |
405 | NITROGEN | 4 | 6 | 872 |
406 | SPECIFICITIES | 9 | 478 | 870 |
407 | INTERACTION | 36 | 105 | 868 |
408 | IMMUNODEFICIENCY | 40 | 78 | 866 |
409 | MEDIATED | 47 | 119 | 866 |
410 | MONOCLONAL | 36 | 141 | 865 |
411 | PROSPECTS | 18 | 58 | 865 |
412 | DIAGNOSIS | 62 | 36 | 864 |
413 | COMPLEX | 34 | 227 | 863 |
414 | UNIT | 34 | 568 | 863 |
415 | RECEPTOR | 17 | 28 | 861 |
416 | IMMUNOGENICITY | 16 | 102 | 859 |
417 | REGULATION | 19 | 62 | 859 |
418 | INDUCTION | 17 | 93 | 858 |
419 | PURIFICATION | 38 | 315 | 855 |
420 | ZONE | 7 | 43 | 855 |
# | Word | Recs | TLCS | TGCS |
421 | ADULTS | 23 | 129 | 854 |
422 | CAUSED | 14 | 80 | 853 |
423 | PERSISTENT | 29 | 238 | 853 |
424 | GROUP | 49 | 162 | 850 |
425 | UNIVERSAL | 7 | 58 | 849 |
426 | EPIDEMIC | 29 | 476 | 847 |
427 | POSTTRANSFUSION | 17 | 363 | 846 |
428 | LECTURE | 6 | 12 | 843 |
429 | AGENT | 17 | 281 | 838 |
430 | ENVELOPE | 24 | 199 | 837 |
431 | SUGAR | 13 | 151 | 835 |
432 | DYSFUNCTION | 17 | 33 | 834 |
433 | SCREENING | 55 | 128 | 833 |
434 | INTERACTIONS | 26 | 107 | 831 |
435 | POLYARTERITIS | 4 | 127 | 829 |
436 | SOUTH | 47 | 266 | 829 |
437 | TUMORS | 24 | 47 | 829 |
438 | FIXATION | 21 | 548 | 828 |
439 | LEPROSY | 47 | 319 | 828 |
440 | COMPLETE | 12 | 62 | 826 |
441 | MAMMALIAN | 16 | 65 | 826 |
442 | STRATEGY | 14 | 12 | 826 |
443 | TRANSFERRINS | 28 | 363 | 825 |
444 | HEMOGLOBIN | 45 | 156 | 823 |
445 | FOLLOWING | 25 | 111 | 822 |
446 | SURVIVAL | 26 | 190 | 817 |
447 | COURSE | 26 | 133 | 815 |
448 | DATA | 35 | 210 | 815 |
449 | MICROSCOPIC | 25 | 294 | 814 |
450 | MIXED | 10 | 16 | 811 |